Calidi Biotherapeutics, Inc. Increase (Decrease) in Interest Payable, Net
Calidi Biotherapeutics, Inc. (CLDI) reported Increase (Decrease) in Interest Payable, Net of $135.87 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-21.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2023-08-21
- Calidi Biotherapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2023-06-30 was $70.43K.
- Calidi Biotherapeutics, Inc. increase (decrease) in interest payable, net for the quarter ending 2023-03-31 was $65.44K.
- Calidi Biotherapeutics, Inc. increase (decrease) in interest payable, net for fiscal 2022 was $7.72K.
| Period end | Increase (Decrease) in Interest Payable, Net 3 month | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|---|
| 2023-06-30 | $70.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-21 | $135.87K 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $65.44K 10-Q · filed 2023-05-15 | ||
| 2022-12-31 | $7.72K 10-K · filed 2023-03-31 | ||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |